STOCK TITAN

Paragon 28 Launches Paratrooper™ Plantar Plate System for Hammertoe and Soft Tissue Repair

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Paragon 28, Inc. (NYSE: FNA) announced the launch of its innovative Paratrooper™ Plantar Plate Repair System, designed to enhance hammertoe and soft-tissue treatment options. This low-profile, all-suture implant aims to improve surgical approaches for plantar plate repair and forefoot deformities. CEO Albert DaCosta highlighted the challenges in treating plantar plate conditions and the company's strategic focus on the growing hammertoe market, suggesting significant opportunities for improved patient outcomes.

Positive
  • Launch of the Paratrooper™ Plantar Plate Repair System expands product offerings.
  • The hammertoe segment is identified as a fast-growing market with potential for improved patient outcomes.
Negative
  • None.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today an expansion of its hammertoe and soft-tissue portfolio with the launch of its Paratrooper™ Plantar Plate Repair System. The Paratrooper™ Plantar Plate System’s low profile, all-suture implant provides surgeons a new and innovative approach for plantar plate repair and forefoot deformities.

Paratrooper™ Plantar Plate System (Graphic: Business Wire)

Paratrooper™ Plantar Plate System (Graphic: Business Wire)

Paragon 28’s CEO, Albert DaCosta, commented, “Repair of the plantar plate has historically been one of the more challenging pathologies within the hammertoe sub-segment. We are thrilled to have developed an all suture-based, low profile and versatile implant capable of treating a variety of plantar plate conditions. The Paratrooper™ Plantar Plate system adds to our growing portfolio of soft tissue products and the Hammertoe segment remains a strategic focus for the company as it is one of the fastest growing markets, with opportunities for significant improvements in patient outcomes.”

The addition of the Paratrooper™ Plantar Plate System bolsters Paragon 28’s hammertoe product offering, which includes the TenoTac™ Soft Tissue Fixation System, HammerTube™ Hammertoe System, Mini-Monster® Screw System, and JAWS Staple System. With this comprehensive portfolio, Paragon 28® provides its customers innovative forefoot solutions to address flexible and rigid contractures of the lesser toes.

About Paragon 28, Inc.

Based in Englewood, CO., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Investor Contact:

Gilmartin Group

Matt Bacso, CFA

matt.bacso@gilmartinir.com

Source: Paragon 28, Inc.

FAQ

What is the Paratrooper™ Plantar Plate Repair System by Paragon 28 (FNA)?

It is a new, low-profile all-suture implant designed for plantar plate repair and to address forefoot deformities.

How does the new system impact Paragon 28's product offerings?

The Paratrooper™ Plantar Plate Repair System enhances Paragon 28's existing hammertoe and soft-tissue product portfolio.

What market segment does Paragon 28 (FNA) focus on?

Paragon 28 focuses exclusively on the foot and ankle orthopedic market.

Who is the CEO of Paragon 28 (FNA)?

The CEO of Paragon 28 is Albert DaCosta.

What are the potential benefits of the new repair system for patients?

The system aims to improve surgical outcomes and reduce complications in treating plantar plate conditions.

Paragon 28, Inc.

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

831.64M
49.79M
40.56%
61.27%
8.11%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ENGLEWOOD